170 related articles for article (PubMed ID: 22669454)
1. Characteristic immunophenotype of solid subtype component in lung adenocarcinoma.
Takuwa T; Ishii G; Nagai K; Yoshida J; Nishimura M; Hishida T; Neri S; Hasegawa S; Ochiai A
Ann Surg Oncol; 2012 Nov; 19(12):3943-52. PubMed ID: 22669454
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of a histologic subtype in small adenocarcinoma of the lung: the impact of nonbronchioloalveolar carcinoma components.
Sakao Y; Miyamoto H; Sakuraba M; Oh T; Shiomi K; Sonobe S; Izumi H
Ann Thorac Surg; 2007 Jan; 83(1):209-14. PubMed ID: 17184664
[TBL] [Abstract][Full Text] [Related]
3. The morphological diversity of small lung adenocarcinoma with mixed subtypes is associated with local invasiveness and prognosis.
Haruki T; Shomori K; Shiomi T; Taniguchi Y; Nakamura H; Ito H
Eur J Cardiothorac Surg; 2011 May; 39(5):763-8. PubMed ID: 20864350
[TBL] [Abstract][Full Text] [Related]
4. Correlation of histological components with tumor invasion in pulmonary adenocarcinoma.
Moon Y; Kim KS; Sung SW; Lee KY; Kim YK; Kang JH; Kim YS; Park JK
World J Surg Oncol; 2014 Dec; 12():388. PubMed ID: 25519483
[TBL] [Abstract][Full Text] [Related]
5. Distinctive histopathological features of lepidic growth predominant node-negative adenocarcinomas 3-5 cm in size.
Takahashi Y; Ishii G; Aokage K; Hishida T; Yoshida J; Nagai K
Lung Cancer; 2013 Feb; 79(2):118-24. PubMed ID: 23177278
[TBL] [Abstract][Full Text] [Related]
6. Second predominant subtype predicts outcomes of intermediate-malignant invasive lung adenocarcinoma†.
Ito M; Miyata Y; Yoshiya T; Tsutani Y; Mimura T; Murakami S; Ito H; Nakayama H; Okada M
Eur J Cardiothorac Surg; 2017 Feb; 51(2):218-222. PubMed ID: 28186287
[TBL] [Abstract][Full Text] [Related]
7. Low papillary structure in lepidic growth component of lung adenocarcinoma: a unique histologic hallmark of aggressive behavior.
Fukutomi T; Hayashi Y; Emoto K; Kamiya K; Kohno M; Sakamoto M
Hum Pathol; 2013 Sep; 44(9):1849-58. PubMed ID: 23648380
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients--based on a hospital study in China.
Song Z; Zhu H; Guo Z; Wu W; Sun W; Zhang Y
Eur J Surg Oncol; 2013 Nov; 39(11):1262-8. PubMed ID: 24063970
[TBL] [Abstract][Full Text] [Related]
9. Excellent prognosis of lepidic-predominant lung adenocarcinoma: low incidence of lymphatic vessel invasion as a key factor.
Araki K; Kidokoro Y; Hosoya K; Wakahara M; Matsuoka Y; Takagi Y; Haruki T; Miwa K; Taniguchi Y; Horie S; Nakamura H
Anticancer Res; 2014 Jun; 34(6):3153-6. PubMed ID: 24922687
[TBL] [Abstract][Full Text] [Related]
10. Comparison of malignant grade between pure and partially invasive types of early lung adenocarcinoma.
Sasada S; Nakayama H; Miyata Y; Tsubokawa N; Mimae T; Yoshiya T; Murakami S; Ito H; Okada M
Ann Thorac Surg; 2015 Mar; 99(3):956-60. PubMed ID: 25620597
[TBL] [Abstract][Full Text] [Related]
11. Histologic features associated with metastatic potential in invasive adenocarcinomas of the lung.
Xu L; Tavora F; Burke A
Am J Surg Pathol; 2013 Jul; 37(7):1100-8. PubMed ID: 23681071
[TBL] [Abstract][Full Text] [Related]
12. Structural and biological properties of a papillary component generating a micropapillary component in lung adenocarcinoma.
Nagano T; Ishii G; Nagai K; Ito T; Kawase A; Takahashi K; Nishimura Y; Nishiwaki Y; Ochiai A
Lung Cancer; 2010 Mar; 67(3):282-9. PubMed ID: 19481833
[TBL] [Abstract][Full Text] [Related]
13. Differences in the prognostic implications of vascular invasion between lung adenocarcinoma and squamous cell carcinoma.
Usui S; Minami Y; Shiozawa T; Iyama S; Satomi K; Sakashita S; Sato Y; Noguchi M
Lung Cancer; 2013 Dec; 82(3):407-12. PubMed ID: 24094286
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping.
Riquet M; Foucault C; Berna P; Assouad J; Dujon A; Danel C
Ann Thorac Surg; 2006 Jun; 81(6):1988-95. PubMed ID: 16731118
[TBL] [Abstract][Full Text] [Related]
15. Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification.
Russell PA; Wainer Z; Wright GM; Daniels M; Conron M; Williams RA
J Thorac Oncol; 2011 Sep; 6(9):1496-504. PubMed ID: 21642859
[TBL] [Abstract][Full Text] [Related]
16. Adenocarcinomas with prominent lepidic spread: retrospective review applying new classification of the American Thoracic Society.
Xu L; Tavora F; Battafarano R; Burke A
Am J Surg Pathol; 2012 Feb; 36(2):273-82. PubMed ID: 22198010
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin K is selectively expressed in the stroma of lung adenocarcinoma but not in bronchioloalveolar carcinoma. A useful marker of invasive growth.
Rapa I; Volante M; Cappia S; Rosas R; Scagliotti GV; Papotti M
Am J Clin Pathol; 2006 Jun; 125(6):847-54. PubMed ID: 16690483
[TBL] [Abstract][Full Text] [Related]
18. Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma.
Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Lappi-Blanco E; Kaarteenaho R
Lung Cancer; 2015 Dec; 90(3):568-74. PubMed ID: 26506915
[TBL] [Abstract][Full Text] [Related]
19. Histological progression of small intrapulmonary metastatic tumor from primary lung adenocarcinoma.
Aokage K; Ishii G; Yoshida J; Hishida T; Nishimura M; Nagai K; Ochiai A
Pathol Int; 2010 Dec; 60(12):765-73. PubMed ID: 21091834
[TBL] [Abstract][Full Text] [Related]
20. Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (Makimoto Y; Nabeshima K; Iwasaki H; Miyoshi T; Enatsu S; Shiraishi T; Iwasaki A; Shirakusa T; Kikuchi M
Histopathology; 2005 Jun; 46(6):677-84. PubMed ID: 15910599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
